申请人:Arrys Therapeutics, Inc.
公开号:US20210300921A1
公开(公告)日:2021-09-30
The present invention provides N-((4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenethyl)carbamoyl)-4-methylbenzenesulfonamide compositions, and the use thereof for treating a proliferative disorder.